Complications of low-dose, echo-guided alcohol septal ablation

Catheterization and Cardiovascular Interventions

Volumn 75, Issue 4, 2010, Pages 546-550

  Veselka, Josef ^a   Zemánek, David ^a   Tomašov, Pavol ^a   Homolová, Stanislava ^a   Adlová, Radka ^a   Tesař, David ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Cardiomyopathy; Hemodynamics; Hypertrophic cardiomyopathy

Indexed keywords

ALCOHOL;

ADULT; ALCOHOL SEPTAL ABLATION; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOVERSION; CATHETER ABLATION; COMPLETE HEART BLOCK; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HOSPITALIZATION; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE;

ADULT; AGED; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, HYPERTROPHIC; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY, AMBULATORY; ETHANOL; FEMALE; HEART BLOCK; HEART CATHETERIZATION; HUMANS; INJECTIONS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TACHYCARDIA, VENTRICULAR; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 77950534288     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22326     Document Type: Article

References (17)

1. Maron BJ, Maron MS, Wigle ED, Braunwald E. The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. J Am Coll Cardiol 2009;54:191-200.
2. Alam M, Dokainish H, Lakkis NM. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy. A systematic review of literature. J Intervent Cardiol 2006;19:319-327. (Pubitemid 44185823)
3. Veselka J. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: A review of the literature. Med Sci Monit 2007;13:RA62-RA68. (Pubitemid 46557764)
4. Veselka J, Duchoňová R, Procházková Š, Páleníčková J, Sorajja P, Tesař D. Effects of varying etanol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomyopathy on early hemodynamic ganges. Am J Cardiol 2005;95:675-678. (Pubitemid 40255269)
5. Veselka J, Duchoňová R, Páleníč ková J, Zemánek D, Tišerová M, Linhartová K, Červinka P. Impact of etanol dosing on the long-term outcfome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy: A single-center, prospective, and randomized study. Circ J 2006;12:1550-1552.
6. Alam M, Dokainish H, Lakkis NM. Hypertrophic obstructive cardiomyopathy-Alcohol septal ablation vs myectomy: A meta-analysis. Eur Heart J 2009;30:1080-1087.
7. Faber L, Welge D, Fassbender D, Schmidt HK, Horstkotte D, Seggewiss H. One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: Predictors of hemodynamic and clinical response. Clin Res Cardiol 2007;96:864-873. (Pubitemid 350164933)
8. Sorajja P, Valeti U, Nishimura RA, Ommen SR, Rihal CS, Gersh BJ, Hodge DO, Schaff HV, Holmes DR. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation 2008;118:131-139.
9. Veselka J, Zemánek D, Duchoňová R, Tomašov P, Linhartová K. Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: Ultra-low dose of alcohol (1 ml) is still effective. Heart Vessels 2009;24:27-31.
10. Lawrenz T, Lieder F, Bartelsmeier M, Leuner C, Borchert B, Meyer Zu Vilsendorf D, Strunk-Mueller C, Reinhardt J, Feuchtl A, Stellbrink C, Kuhn H. Predictors of complete heart block after transcoronary ablation of septal hypertrophy: Results of a prospective electrophysiological investigation in 172 patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2007;49:2356-2363. (Pubitemid 46891717)
11. Kuhn H, Lawrenz T, Lieder F, Leuner C, Strunk-Mueller C, Obergassel L, Bartelsmeier M, Stellbrink C. Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): A 10 year experience. Clin Res Cardiol 2008;97:234-243.
12. Li ZQ, Cheng TO, Zhang WW, Qiao SB, Zhao LY, Jin YZ, Guan RM, Liu L. Percutaneous transluminal septal ablation for hypertrophic obstructive cardiomyopathy: The Chinese experience in 119 patients from a single center. Int J Cardiol 2004;93:197-202. (Pubitemid 38229587)
13. Veselka J, Zemánek D, Fiedler J, Šváb P. Real-time myocardial contrast echocardiography for echo-guided alcohol septal ablation. Arch Med Sci 2009;5:271-272.
14. Antoun P, El Masry H, Breall JA. Sudden cardiac death complicating alcohol septal ablation: A case report and review of literature. Catheter Cardiovasc Interv 2009;73:956-959.
15. Boltwood CM, Chien W, Ports T. Ventricular tachycardia complicating alcohol septal ablation. N Engl J Med 2004;351:1914-1915. (Pubitemid 39426334)
16. Simon RD, Crawford FA, Spencer WH, Gold MR. Sustained ventricular tachycardia following alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Pacing Clin Electrophysiol 2005;28:1354-1356. (Pubitemid 43951397)
17. Streit S, Walpoth N, Windecker S, Meier B, Hess OM. Is alcohol ablation of the septum associated with recurrent tacharrhythmias? Swiss Med Wkl 2007;137:660-668.